Watson Pharmaceuticals Inc Deals

Summary

Reasons to purchase (USPs and key questions answered)

Partneringdesk Watson Pharmaceuticals Inc Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:

• identifying active partners
• tracking competitor activity
• benchmarking deals
• comparing the finances of different deal types.

Partneringdesk Watson Pharmaceuticals Inc Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Watson
Pharmaceuticals Inc.

Report scope

The report contains:

• a brief company profile including subsidiary names
• financial information where disclosed
• a deals overview
• specialized indexes including deals by partner company, subsidiary company, therapy focus and development stage
• a detailed listing of the company's deals and alliances.

Forecasts, projections, market estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.

Description

Partneringdesk Watson Pharmaceuticals Inc Deals briefing provides an in-depth view of the 24 deals made by Watson Pharmaceuticals Inc and its subsidiaries with 25 partnering companies between 2000 and 2005, in a clear and accessible PDF format.

Chapter 1: Company profile

An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

A detailed listing of all the company's deals and alliances announced between January 2000 and July 2005.

Pharmaceutical Executive Top 50, May 2005

Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.

Who should buy the report

This report is essential reading for board and executive management, and individuals in:

• business development
• licensing/partnering
• deal making
• business strategy
• marketing and promotion
• distribution and manufacturing (including contract services).

Methodology

This report is derived from data obtained from Pharmalicensing's Partneringdesk deals and alliances database. The database is updated daily using industry sources.

Companies analyzed/mentioned

The report includes deals made by Watson Pharmaceuticals Inc between January 2000 and July 2005 and the following subsidiaries (where available):

• Amarin Development AB
• Makoff R&D Laboratories Inc
• Schein Pharmaceutical (Bermuda)
• Schein Pharmaceutical Canada
• Schein Pharmaceutical Inc
• Watson Pharma Inc

Report summary

Partneringdesk Watson Pharmaceuticals Inc Deals briefing provides an in-depth view of the 24 deals made by Watson Pharmaceuticals Inc and its subsidiaries with 25 partnering companies between 2000 and 2005, in a clear and accessible PDF format.

Contents

• Introduction
• About Partneringdesk Deals briefings
• Chapter 1: Company profile
• Chapter 2: Financial data and deals overview
• Chapter 3: Summary of deals
  • Deals involving Watson Pharmaceuticals Inc by partner company
  • Deals involving Watson Pharmaceuticals Inc by subsidiary
  • Deals involving Watson Pharmaceuticals Inc by therapy focus
  • Deals involving Watson Pharmaceuticals Inc by development stage
• Chapter 4: List of deals
  • Glossary
• List of tables, charts
  • Table 2.1 Watson Pharmaceuticals Inc financial summary
  • Table 2.2 Watson Pharmaceuticals Inc deals by deal type
  • Table 2.3 Watson Pharmaceuticals Inc deals by therapy focus
  • Table 2.4 Watson Pharmaceuticals Inc deals by development stage
  • Table 2.5 Watson Pharmaceuticals Inc deals by industry sector